Fourth Quarter Revenue Increases 73% to
Financial Summary:
| Three Months Ended | Year Ended | |||||||||||||||||||||||
$ in millions | 2026 | 2025 | % Change | 2026 | 2025 | % Change | ||||||||||||||||||
Revenue | $ | 21.2 | $ | 12.2 | 73.8 | % | $ | 71.7 | $ | 37.2 | 92.7 | % | ||||||||||||
Gross Profit | $ | 8.3 | $ | 2.7 | 207.4 | % | $ | 25.8 | $ | 10.1 | 155.4 | % | ||||||||||||
Operating Expenses* | $ | 12.6 | $ | 7.2 | 75.0 | % | $ | 45.5 | $ | 22.0 | 106.8 | % | ||||||||||||
Net Income (Loss) | $ | (4.1 | ) | $ | (7.1 | ) | -42.3 | % | $ | (20.5 | ) | $ | (14.9 | ) | 37.6 | % | ||||||||
Adjusted EBITDA** (non-GAAP) | $ | 2.1 | $ | (2.0 | ) | -205.0 | % | $ | 4.2 | $ | (5.1 | ) | -182.4 | % | ||||||||||
*Inclusive of
**Reconciliation of this non-GAAP financial measure is provided below. Percentage changes for net loss and adjusted EBITDA are calculated on absolute values.
Fourth Quarter Fiscal 2026 & Subsequent Highlights:
- Ended fiscal 2026 with a record order backlog of approximately
$110.9 million , up 197% from$37.4 million atJune 30, 2025 , of which approximately$85.6 million is scheduled for delivery to customers within the next twelve months. - Completed a
$50.0 million primary offering of common stock at$14.00 per share inJune 2026 , closing the fiscal year with a strong balance sheet of$93.2 million of cash and cash equivalents. - Received an
$11 million follow-on infrared camera order from a leading global technology customer for counter-unmanned aircraft system (UAS) applications and$13 million in follow-on optical assembly orders from a leading counter-UAS and defense systems supplier. - Signed definitive agreement to divest the Company's subsidiary,
LightPath (Zhenjiang) Optical Instrumentation Co., Ltd. ("LPOIZ"), including its manufacturing facility and operations inChina , for$4.5 million , payable in installments over five years, completing LightPath's transition to a fully Western-aligned manufacturing footprint.
Management Commentary
"The fourth quarter set the high-water mark on every measure that matters to us. Backlog finished the fiscal year at
"LightPath has also been the beneficiary of legislation enacted in
"Fiscal 2027 is now about capacity and conversion. We roughly doubled our glass melting capacity with AML and expect that we will need to continue to increase capacity based on projected demand. We are adding melting capability in both our
Fourth Quarter Fiscal 2026 Financial Results
Revenue for the fourth quarter of fiscal 2026 increased 73% to
Product Group Revenue | Fourth Quarter of | Fourth Quarter of | ||||||||||
($ in millions)** | Fiscal 2026 | Fiscal 2025 | % Change | |||||||||
Infrared ("IR") Components | $ | 7.1 | $ | 4.9 | 45 | % | ||||||
Visible Components | $ | 4.2 | $ | 2.8 | 50 | % | ||||||
Assemblies & Modules | $ | 9.1 | $ | 4.2 | 117 | % | ||||||
| $ | 0.8 | $ | 0.3 | 167 | % | |||||||
*** Numbers may not foot due to rounding. Certain fiscal 2025 amounts have been reclassified from infrared components to assemblies and modules to conform to the current classification.
Growth in infrared components was driven by
Gross profit increased 210% to
Operating expenses for the fourth quarter of fiscal 2026 were
Net loss in the fourth quarter of fiscal 2026 improved to
Adjusted EBITDA** for the fourth quarter of fiscal 2026 grew to
Cash and cash equivalents as of
Fiscal Year 2026 Financial Results
Revenue for fiscal 2026 increased 93% to
Product Group Revenue | ||||||||||||
($ in millions)** | Fiscal 2026 | Fiscal 2025 | % Change | |||||||||
IR Components | $ | 21.2 | $ | 14.3 | 48 | % | ||||||
Visible Components | $ | 15.5 | $ | 11.7 | 32 | % | ||||||
Assemblies & Modules | $ | 31.9 | $ | 8.0 | 299 | % | ||||||
| $ | 3.2 | $ | 3.2 | 0 | % | |||||||
*** Numbers may not foot due to rounding. Certain fiscal 2025 amounts have been reclassified from infrared components to assemblies and modules to conform to the current classification.
Gross profit increased 155% to
Operating expenses for fiscal 2026 were
Net loss for fiscal 2026 totaled
Adjusted EBITDA for fiscal 2026 grew to
Fourth Quarter and Fiscal 2026 Earnings Call
Management will host an investor conference call at
Q4 FY2026 Earnings Conference Call
Date:
Time:
International Dial-in: 1-203-518-9783
Conference ID: LIGHT
Webcast: LPTH Q4 FY2026 Earnings Conference Call
Please join at least five minutes before the start of the call to ensure timely participation.
A playback of the call will be available through
About
**Use of Non-GAAP Financial Measures
To provide investors with additional information regarding financial results, this press release includes references to EBITDA and adjusted EBITDA, which are non-GAAP financial measures. The Company calculates EBITDA by adjusting net income to exclude net interest expense, income tax expense or benefit, depreciation, and amortization. We also calculate adjusted EBITDA, which excludes, as applicable: (1) stock compensation expenses; (2) the loss on extinguishment of debt; (3) the effect of the non-cash income or expense associated with the mark-to-market adjustments related to the warrants; (4) the effect of non-cash income or expenses associated with the fair value adjustments related to the acquisition earnout liabilities; (5) acquisition costs, including legal fees and due diligence; and (6) the effect of foreign exchange gains or losses.
A "non-GAAP financial measure" is generally defined as a numerical measure of a company's historical or future performance that excludes or includes amounts, or is subject to adjustments, so as to be different from the most directly comparable measure calculated and presented in accordance with GAAP. The Company's management believes that these non-GAAP financial measures, when considered together with the GAAP financial measures, provide information that is useful to investors in understanding period-over-period operating results separate and apart from items that may, or could, have a disproportionately positive or negative impact on results in any particular period. Management also believes that these non-GAAP financial measures enhance the ability of investors to analyze underlying business operations and understand performance. In addition, management may utilize these non-GAAP financial measures as guides in forecasting, budgeting, and planning. Non-GAAP financial measures should be considered in addition to, and not as a substitute for, or superior to, financial measures presented in accordance with GAAP. A reconciliation of these non-GAAP financial measures with the most directly comparable financial measures calculated in accordance with GAAP is presented in the table below.
Reconciliation of Non-GAAP Financial Measures and Regulation G Disclosure
| (unaudited) | ||||||||||||||||
| Three Months Ended | Year Ended | |||||||||||||||
| 2026 | 2025 | 2026 | 2025 | |||||||||||||
Net loss | $ | (4,140,865 | ) | $ | (7,055,980 | ) | $ | (20,545,563 | ) | $ | (14,873,182 | ) | ||||
Depreciation and amortization | 1,320,375 | 792,488 | 5,038,066 | 4,149,240 | ||||||||||||
Income tax provision | 111,497 | (122,402 | ) | 314,713 | 37,790 | |||||||||||
Interest (income) expense | (298,238 | ) | 312,967 | (16,003 | ) | 1,118,213 | ||||||||||
EBITDA | $ | (3,007,231 | ) | $ | (6,072,927 | ) | $ | (15,208,787 | ) | $ | (9,567,939 | ) | ||||
Stock-based compensation | 1,600,218 | 298,309 | 2,861,795 | 1,043,464 | ||||||||||||
Loss on extinguishment of debt | - | - | 506,280 | 418,502 | ||||||||||||
Change in fair value of warrant liability | - | 2,224,270 | - | 1,353,716 | ||||||||||||
Change in fair value of acquisition liabilities | 3,401,807 | 1,430,000 | 15,636,336 | 1,560,445 | ||||||||||||
Acquisition costs | 70,273 | 290,448 | - | |||||||||||||
Foreign exchange loss | 30,796 | 141,583 | 146,060 | 129,882 | ||||||||||||
Adjusted EBITDA | $ | 2,095,863 | $ | (1,978,765 | ) | $ | 4,232,132 | $ | (5,061,930 | ) | ||||||
% of revenue | 10 | % | -16 | % | 6 | % | -14 | % | ||||||||
Forward-Looking Statements
This press release includes statements that constitute forward-looking statements made pursuant to the safe harbor provisions of the Private Securities Litigation Reform Act of 1995. Forward-looking statements may be identified by the use of words such as "forecast," "guidance," "plan," "estimate," "will," "would," "project," "maintain," "intend," "expect," "anticipate," "prospect," "strategy," "future," "likely," "may," "should," "believe," "continue," "opportunity," "potential," and other similar expressions that predict or indicate future events or trends or that are not statements of historical matters. These forward-looking statements include, without limitation, statements regarding: (i) the Company's ability to convert its backlog into revenue and the timing of such conversion; (ii) expectations regarding demand for germanium alternatives and the effect of
Investor Relations Contact
Managing Director
LPTH@mzgroup.us
+1 (949) 259-4987
Consolidated Balance Sheets
(unaudited)
Assets | 2026 | 2025 | ||||||
Current assets: | ||||||||
Cash and cash equivalents | $ | 93,204,655 | $ | 4,877,036 | ||||
Trade accounts receivable, net of allowance of | 15,112,908 | 9,455,310 | ||||||
Inventories, net | 18,005,559 | 12,858,838 | ||||||
Prepaid expenses and deposits | 3,457,300 | 1,142,661 | ||||||
Other current assets | 116,028 | 40,150 | ||||||
Total current assets | 129,896,450 | 28,373,995 | ||||||
Property and equipment, net | 19,363,026 | 15,864,061 | ||||||
Operating lease right-of-use assets | 8,115,887 | 7,429,378 | ||||||
Intangible assets, net | 17,134,601 | 15,987,923 | ||||||
| 19,315,177 | 13,753,921 | |||||||
Deferred tax assets, net | 85,902 | 22,571 | ||||||
Other assets | 96,578 | 73,917 | ||||||
Total assets | $ | 194,007,621 | $ | 81,505,766 | ||||
Liabilities and Stockholders' Equity | ||||||||
Current liabilities: | ||||||||
Accounts payable | $ | 7,686,144 | $ | 7,421,430 | ||||
Accrued liabilities | 12,779,784 | 5,686,396 | ||||||
Accrued payroll and benefits | 4,139,586 | 2,359,152 | ||||||
Operating lease liabilities, current | 1,189,908 | 1,254,062 | ||||||
Loans payable, current portion | 112,317 | 172,567 | ||||||
Finance lease obligation, current portion | 269,414 | 206,518 | ||||||
Total current liabilities | 26,177,153 | 17,100,125 | ||||||
Deferred tax liabilities, net | 95,084 | 152,760 | ||||||
Accrued liabilities, noncurrent | - | 823,000 | ||||||
Finance lease obligation, less current portion | 392,796 | 421,363 | ||||||
Operating lease liabilities, noncurrent | 8,888,227 | 8,326,250 | ||||||
Loans payable, less current portion | 74,878 | 4,804,990 | ||||||
Total liabilities | 35,628,138 | 31,628,488 | ||||||
Commitments and Contingencies | ||||||||
Series G Convertible Preferred Stock; | 8,906,686 | 34,232,510 | ||||||
Stockholders' equity: | ||||||||
Preferred stock: Series D, | - | - | ||||||
Common stock: Class A, | 699,630 | 429,493 | ||||||
Additional paid-in capital | 398,726,619 | 244,953,346 | ||||||
Accumulated other comprehensive income | 1,308,868 | 978,686 | ||||||
Accumulated deficit | (251,262,320 | ) | (230,716,757 | ) | ||||
Total stockholders' equity | 149,472,797 | 15,644,768 | ||||||
Total liabilities, convertible preferred stock and stockholders' equity | $ | 194,007,621 | $ | 81,505,766 | ||||
Consolidated Statements of Comprehensive Income (Loss)
(unaudited)
| Three Months Ended | Year Ended | |||||||||||||||
| 2026 | 2025 | 2026 | 2025 | |||||||||||||
Revenue, net | $ | 21,162,352 | $ | 12,209,793 | $ | 71,722,099 | $ | 37,202,630 | ||||||||
Cost of sales | 12,816,746 | 9,519,040 | 45,917,308 | 27,072,516 | ||||||||||||
Gross profit | 8,345,606 | 2,690,753 | 25,804,791 | 10,130,114 | ||||||||||||
Operating expenses: | ||||||||||||||||
Selling, general and administrative | 8,120,886 | 4,739,622 | 24,660,503 | 15,814,627 | ||||||||||||
New product development | 1,125,978 | 1,064,997 | 3,784,029 | 3,063,772 | ||||||||||||
Amortization of intangible assets | 455,025 | (54,695 | ) | 1,833,320 | 1,414,817 | |||||||||||
Change in fair value of acquisition liabilities | 3,401,807 | 1,430,000 | 15,636,336 | 1,560,445 | ||||||||||||
(Gain) loss on disposal of property and equipment | (459,108 | ) | 18,829 | (455,092 | ) | 99,334 | ||||||||||
Total operating expenses | 12,644,588 | 7,198,753 | 45,459,096 | 21,952,995 | ||||||||||||
Operating loss | (4,298,982 | ) | (4,508,000 | ) | (19,654,305 | ) | (11,822,881 | ) | ||||||||
Other income (expense): | ||||||||||||||||
Interest income (expense), net | 298,238 | (312,967 | ) | 16,003 | (1,118,213 | ) | ||||||||||
Loss on extinguishment of debt | - | - | (506,280 | ) | (418,502 | ) | ||||||||||
Change in fair value of warrant liability | - | (2,224,270 | ) | - | (1,353,716 | ) | ||||||||||
Other expense, net | (28,624 | ) | (133,145 | ) | (86,268 | ) | (122,080 | ) | ||||||||
Total other income (expense), net | 269,614 | (2,670,382 | ) | (576,545 | ) | (3,012,511 | ) | |||||||||
Loss before income taxes | (4,029,368 | ) | (7,178,382 | ) | (20,230,850 | ) | (14,835,392 | ) | ||||||||
Income tax provision | 111,497 | (122,402 | ) | 314,713 | 37,790 | |||||||||||
Net loss | $ | (4,140,865 | ) | $ | (7,055,980 | ) | $ | (20,545,563 | ) | $ | (14,873,182 | ) | ||||
Foreign currency translation adjustment | - | 527,619 | 330,182 | 468,750 | ||||||||||||
Comprehensive loss | $ | (4,140,865 | ) | $ | (6,528,361 | ) | $ | (20,215,381 | ) | $ | (14,404,432 | ) | ||||
Loss per common share (basic) | $ | (0.06 | ) | $ | (0.16 | ) | $ | (0.38 | ) | $ | (0.36 | ) | ||||
Number of shares used in per share calculation (basic) | 64,820,263 | 42,874,607 | 53,374,275 | 40,874,068 | ||||||||||||
Loss per common share (diluted) | $ | (0.06 | ) | $ | (0.16 | ) | $ | (0.38 | ) | $ | (0.36 | ) | ||||
Number of shares used in per share calculation (diluted) | 64,820,263 | 42,874,607 | 53,374,275 | 40,874,068 | ||||||||||||
Consolidated Statements of Changes in Stockholders' Equity
(unaudited)
| Temporary Equity | Accumulated | |||||||||||||||||||||||
| Series G Convertible | Class A | Additional | Other | Total | ||||||||||||||||||||
| Preferred Stock | Common Stock | Paid-in | Comprehensive | Accumulated | Stockholders' | |||||||||||||||||||
| Shares | Amount | Shares | Amount | Capital | Income | Deficit | Equity | |||||||||||||||||
Balances at | - | - | 39,254,643 | $ | 392,546 | $ | 245,140,758 | $ | 509,936 | $ | (215,843,575 | ) | $ | 30,199,665 | ||||||||||
Issuance of preferred stock under private equity placement, net of fees | 24,956 | 19,481,376 | - | - | - | - | - | - | ||||||||||||||||
Issuance of common stock for: | ||||||||||||||||||||||||
Employee Stock Purchase Plan | - | - | 9,369 | 93 | 14,292 | - | - | 14,385 | ||||||||||||||||
Exercise of stock options, RSUs & RSAs, net | - | - | 593,791 | 5,938 | (2,763 | ) | - | - | 3,175 | |||||||||||||||
Shares issued as compensation | - | - | 49,000 | 490 | 89,180 | - | - | 89,670 | ||||||||||||||||
Issuance of common stock for acquisition of Visimid | - | - | 382,253 | 3,823 | 710,123 | - | - | 713,946 | ||||||||||||||||
Issuance of common stock for acquisition of G5 | - | - | 1,972,501 | 19,725 | 4,852,343 | - | - | 4,872,068 | ||||||||||||||||
Issuance of common stock under private equity placement, net of fees | - | - | 687,750 | 6,878 | 1,584,014 | - | - | 1,590,892 | ||||||||||||||||
Issuance of warrants under private equity placement, net of fees | - | - | - | - | 177,445 | - | - | 177,445 | ||||||||||||||||
Preferred cumulative dividends plus accretion | - | 14,751,134 | - | - | (14,751,134 | ) | - | - | (14,751,134 | ) | ||||||||||||||
Stock-based compensation on stock options, RSUs & RSAs | - | - | - | - | 953,795 | - | - | 953,795 | ||||||||||||||||
Reclassification of warrant liability | - | - | - | - | 6,185,293 | - | - | 6,185,293 | ||||||||||||||||
Foreign currency translation adjustment | - | - | - | - | - | 468,750 | 468,750 | |||||||||||||||||
Net loss | - | - | - | - | - | - | (14,873,182 | ) | (14,873,182 | ) | ||||||||||||||
Balances at | 24,956 | 34,232,510 | 42,949,307 | 429,493 | 244,953,346 | 978,686 | (230,716,757 | ) | 15,644,768 | |||||||||||||||
Issuance of preferred stock under private equity placement, net of fees | - | - | - | - | - | - | - | - | ||||||||||||||||
Issuance of common stock for: | ||||||||||||||||||||||||
Employee Stock Purchase Plan | - | - | 2,302 | 23 | 24,839 | - | - | 24,862 | ||||||||||||||||
Exercise of stock options, RSUs & RSAs, net | - | - | 242,617 | 2,427 | 10,076 | - | - | 12,503 | ||||||||||||||||
Exercise of warrants | - | - | 3,468,698 | 34,687 | (34,687 | ) | - | - | - | |||||||||||||||
Issuance of common stock under private equity placement, net of fees | - | - | 1,600,000 | 16,000 | 7,878,045 | - | - | 7,894,045 | ||||||||||||||||
Issuance of common stock under public equity placements, net of fees | - | - | 12,483,900 | 124,839 | 112,212,283 | - | - | 112,337,122 | ||||||||||||||||
Issuance of common stock for acquisition of Visimid | - | - | 112,323 | 1,123 | 348,877 | - | - | 350,000 | ||||||||||||||||
Issuance of common stock for acquisition of Amorphous | - | - | 114,356 | 1,143 | 1,569,302 | - | - | 1,570,445 | ||||||||||||||||
Issuance of common stock for acquisition of G5 | - | - | 297,445 | 2,974 | 3,569,340 | - | - | 3,572,314 | ||||||||||||||||
Conversion of Series G Preferred to Common | (18,464 | ) | (25,325,824 | ) | 8,692,097 | 86,921 | 25,238,903 | - | - | 25,325,824 | ||||||||||||||
Stock-based compensation on stock options, RSUs & RSAs | - | - | - | - | 2,956,295 | - | - | 2,956,295 | ||||||||||||||||
Foreign currency translation adjustment | - | - | - | - | - | 330,182 | - | 330,182 | ||||||||||||||||
Net loss | - | - | - | - | - | - | (20,545,563 | ) | (20,545,563 | ) | ||||||||||||||
Balances at | 6,492 | $ | 8,906,686 | 69,963,045 | $ | 699,630 | $ | 398,726,619 | $ | 1,308,868 | $ | (251,262,320 | ) | $ | 149,472,797 | |||||||||
Condensed Consolidated Statements of Cash Flows
(unaudited)
| Year Ended | ||||||||
| 2026 | 2025 | |||||||
Cash flows from operating activities: | ||||||||
Net loss | $ | (20,545,563 | ) | $ | (14,873,182 | ) | ||
Adjustments to reconcile net loss to net cash used in operating activities: | ||||||||
Depreciation and amortization | 5,038,066 | 4,149,240 | ||||||
Interest from amortization of loan issuance costs | 90,124 | 213,829 | ||||||
Loss on extinguishment of debt | 90,321 | 71,215 | ||||||
Warrant issuance costs | 506,280 | 418,502 | ||||||
Change in fair value of warrant liability | - | 1,353,716 | ||||||
Change in fair value of acquisition earnout liabilities | 15,636,336 | 1,560,445 | ||||||
Earnout payment for acquisition of G5, net of financing portion | (3,813,587 | ) | - | |||||
(Gain) loss on disposal of property and equipment | (455,092 | ) | 99,334 | |||||
Stock-based compensation on stock options, RSUs & RSAs, net | 2,861,795 | 1,043,464 | ||||||
Provision for credit losses | (44,090 | ) | (3,014 | ) | ||||
Change in operating lease assets and liabilities | (188,686 | ) | (273,624 | ) | ||||
Inventory write-offs to allowance | 368,891 | 143,362 | ||||||
Deferred taxes | (121,007 | ) | (221,977 | ) | ||||
Changes in operating assets and liabilities, net of acquisitions: | ||||||||
Trade accounts receivable | (5,578,692 | ) | (2,626,267 | ) | ||||
Other current assets | (75,878 | ) | 91,027 | |||||
Inventories | (5,062,213 | ) | (1,385,690 | ) | ||||
Prepaid expenses and deposits | (2,242,800 | ) | (325,915 | ) | ||||
Accounts payable and accrued liabilities | 3,310,607 | 2,234,145 | ||||||
Net cash used in operating activities | (10,225,188 | ) | (8,331,390 | ) | ||||
Cash flows from investing activities: | ||||||||
Purchase of property and equipment | (6,268,334 | ) | (1,262,302 | ) | ||||
Proceeds from sale of equipment | 475,000 | 10,648 | ||||||
Acquisition of Amorphous | (7,000,111 | ) | - | |||||
Acquisition of G5 Infrared | - | (18,486,669 | ) | |||||
Net cash used in investing activities | (12,793,445 | ) | (19,738,323 | ) | ||||
Cash flows from financing activities: | ||||||||
Proceeds from exercise of stock options | 12,503 | 3,175 | ||||||
Proceeds from sale of common stock from Employee Stock Purchase Plan | 24,862 | 14,385 | ||||||
Proceeds from issuance of common stock under public equity placement, net of fees | 112,337,122 | - | ||||||
Proceeds from issuance of common stock under private equity placement, net of fees | 7,894,045 | 437,725 | ||||||
Proceeds from issuance of preferred stock under private equity placement, net of fees | - | 18,675,026 | ||||||
Proceeds from issuance of warrants under private equity placement, net of fees | - | 4,620,561 | ||||||
Earnout payment for acquisition of G5, net of operating portion | (3,536,471 | ) | - | |||||
Deferred payment for acquisition of Visimid | - | (125,000 | ) | |||||
Borrowings on loans payable | - | 6,659,596 | ||||||
Loan issuance costs | - | (597,465 | ) | |||||
Payments on loans payable | (5,471,522 | ) | (204,100 | ) | ||||
Repayment of finance lease obligations | (236,240 | ) | (187,626 | ) | ||||
Net cash provided by financing activities | 111,024,299 | 29,296,277 | ||||||
Effect of exchange rate on cash and cash equivalents | 321,953 | 170,204 | ||||||
Change in cash, cash equivalents and restricted cash | 88,327,619 | 1,396,768 | ||||||
Cash and cash equivalents, beginning of period | 4,877,036 | 3,480,268 | ||||||
Cash and cash equivalents, end of period | $ | 93,204,655 | $ | 4,877,036 | ||||
Supplemental disclosure of cash flow information: | ||||||||
Interest paid in cash | $ | 409,637 | $ | 273,476 | ||||
Income taxes paid | $ | 325,636 | $ | 206,121 | ||||
Supplemental disclosure of non-cash investing & financing activities: | ||||||||
Purchase of equipment through finance lease arrangements | $ | 275,471 | $ | 93,048 | ||||
Operating right-of-use assets acquired in exchange for operating lease liabilities | $ | 1,956,911 | $ | - | ||||
Issuance of common stock for acquisition of Visimid | $ | 350,000 | $ | 713,946 | ||||
Issuance of common stock for acquisition of G5, including earnouts | $ | 3,572,314 | $ | 4,872,068 | ||||
Issuance of common stock for acquisition of AML, including earnouts | $ | 1,570,445 | $ | - | ||||
Accrual of earnout consideration for acquisition of G5 | $ | - | $ | 3,536,471 | ||||
Accrual of earnout consideration for acquisition of AML | $ | 1,780,000 | $ | - | ||||
Extinguishment of debt in exchange for common stock, preferred stock, warrants and a note | $ | - | $ | 3,057,110 | ||||
SOURCE:
View the original press release on ACCESS Newswire